NCT01994265View on ClinicalTrials.gov

Cognitive Impairment Related to Atrial Fibrillation Prevention Trial

PHASE4CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

November 7, 2014

Primary Completion Date

March 9, 2021

Study Completion Date

March 9, 2021

Conditions

Atrial Fibrillation

Interventions

DRUG

Warfarin

Warfarin once daily, at fast, targeting INR between 2 and 3

DRUG

Dabigatran

Trial Locations (2)

30130100

Federal Univeristy of Minas Gerais, Belo Horizonte

05403-000

Heart Institute - University of São Paulo, São Paulo

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Federal University of Minas Gerais

OTHER

collaborator

Boehringer Ingelheim

INDUSTRY

lead

University of Sao Paulo

OTHER